convalescent anti-SARS-CoV-2 plasma
/ Hvidovre Hospital
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
August 04, 2022
CCAP: Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia
(clinicaltrials.gov)
- P3 | N=147 | Terminated | Sponsor: Thomas Benfield | N=1100 ➔ 147 | Recruiting ➔ Terminated; DSMB advise due to high probability of futility
Enrollment change • Trial termination • Infectious Disease • Novel Coronavirus Disease • Pneumonia • Respiratory Diseases
May 29, 2020
CCAP: Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia
(clinicaltrials.gov)
- P3; N=1500; Recruiting; Sponsor: Thomas Benfield; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open • Infectious Disease • Novel Coronavirus Disease • Pneumonia • Respiratory Diseases
April 14, 2020
CCAP: Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia
(clinicaltrials.gov)
- P3; N=1500; Not yet recruiting; Sponsor: Thomas Benfield
Clinical • New P3 trial • Infectious Disease • Novel Coronavirus Disease • Pneumonia • Pulmonary Disease • Respiratory Diseases
1 to 3
Of
3
Go to page
1